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ABSTRACT GABA is the major inhibitory neurotransmitter in the nervous system and acts at a variety of receptors including
GABAC receptors,which areasubclassofGABAA receptors.Herewehaveusedmolecular dynamics simulationsofGABAdocked
into the extracellular domain of the GABAC receptor to explain the molecular interactions of the neurotransmitter with the residues
that contribute to the binding site; in particular, we have explored the interaction of GABAwith Arg104. The simulations suggest that
the amine group of GABA forms cation-p interactions with Tyr102 and Tyr198, and hydrogen-bonds with Gln83, Glu220, Ser243, and
Ser168, and, most prominently, with Arg104. Substituting Arg104 with Ala, Glu, or Lys, which experimentally disrupt GABAC receptor
function, and repeating the simulation revealed fewer and different bonding patterns with GABA, or the rapid exit of GABA from the
binding pocket. The simulations therefore unveil interactions of GABA within the binding pocket, and explain experimental data,
which indicate that Arg104 is critical for the efﬁcient functioning of the receptor.
INTRODUCTION
GABAC receptors, which are a subfamily of GABAA re-
ceptors, are members of the Cys-loop superfamily of ligand-
gated ion channels (LGICs), an important group of receptors
involved in rapid synaptic transmission and whose mal-
function can result in a variety of neurological disorders;
hence, understanding their mechanism of action is of con-
siderable pharmacological interest. GABAC receptors are
mostly located in retinal neurons where they play a role in
retinal signaling and may be involved in diseases such as
macromolecular degeneration (1). The receptors are activated
by the binding of GABA, the main inhibitory neurotrans-
mitter in the central nervous system. GABAC receptors have
distinct pharmacological properties from GABAA receptors,
e.g., they are not inhibited by bicuculline, the classic GABAA
receptor antagonist (2,3).
Like all the LGICs belonging to the Cys-loop superfamily,
GABAC receptors are composed of ﬁve subunits arranged in
a pentagonal array around a central ion-permeant pore. Each
subunit has an extracellular N-terminal domain (ECD), a
transmembrane domain composed of four a-helices, and an
intracellular domain. Three subunits (r1–3) have been iden-
tiﬁed; these can all form functional homomeric or hetero-
meric receptors (4). Our study is focused on the homomeric
receptors consisting of r1 subunits.
Due to the lack of detailed structural information for
GABAC receptors, homology models of its ECD have been
computer-generated using, as a template, the structures of the
acetylcholine binding protein (AChBP), a protein homo-
logous to the ECD of LGICs of the Cys-loop superfamily
(5–8).
GABA binds in its zwitterionic form, with the negative
charge localized in the carboxylate group and the positive
charge in the amine group (9). The alleged GABA binding
site, shown in Fig. 1, is at the interface between subunits and
is constituted by residues associated with several noncon-
tiguous loops (A–F), including several aromatic residues
(Tyr102 in loop D, Tyr198 in loop B, and Tyr241 and Tyr247 in
loop C), which form the classic Cys-loop receptor aromatic
‘‘box,’’ and polar and charged residues (Gln83, Arg104 in
loop D, Arg158 and Ser168 in loop E, Glu220 in loop F, and
Ser243 in loop C). Docking studies indicate that the amine
group of GABA is inside the tyrosine-made aromatic cage,
while the GABA carboxylate group is likely to be located in
between the positively charged Arg104 and Arg158 (5,6).
Mutagenesis experiments, combined with Hartree-Fock
calculations, conﬁrmed the amine orientation by identifying
a cation-p interaction with Tyr198 (10). The roles of the
charged and hydrophilic residues located in or close to the
alleged binding site were also investigated by mutagenesis
experiments: the results showed that two arginines, Arg104
and Arg158, are crucial for the binding of GABA and/or for
receptor function (6). In fact, the substitution of Arg104 with
either Ala or Glu resulted in .10,000-fold increases in
EC50s, while the substitution with Lys resulted in nonfunc-
tional receptors; the substitution of Arg158 with Ala, Glu, and
Lys resulted in nonfunctional receptors.
Experimental data suggest that the orientation of GABA in
GABAC receptors is subtly different from that in GABAA
receptors, where the neurotransmitter has been shown to have
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a cation-p interaction with an A-loop (rather than a B-loop)
residue (11). In the GABAC receptor, both Arg
104 and Arg158
have been shown, experimentally, to be important for bind-
ing and/or function, while in the GABAA, receptor aArg
66,
the residue equivalent to Arg104, has been shown to be im-
portant for receptor function (12,13) and is proposed to form
a part of a crown of arginines that stabilize the carboxylate
group (14).
To explore the interactions of GABA in the binding site,
we performed molecular dynamic (MD) simulations of a
homology model of the GABAC receptor ECD in water to
validate the homology model and assess the interactions of
GABA inside the alleged binding site. We then focused on
the role of Arg104 by mimicking previous mutagenesis ex-
periments that evaluated how substitution with Ala, Glu, and
Lys affected receptor function (6).
METHODS
For the classical molecular dynamics simulations we used the AMBER2003
force ﬁeld (15) and the AMBER simulation package (16). The initial
structure was the homology model for the GABAC receptor ECD with the
neurotransmitter GABA docked in.
Brieﬂy, using FUGUE (17), the sequence of the r1 subunit of the human
GABAC receptor was aligned to the AChBP sequence, based on the 2.7 A˚
resolution structure from Lymnaea stagnalis (18), as shown in Fig. 2. This is
considered to be a ligand-bound structure and therefore is an appropriate
template for ligand binding studies.
The three-dimensional models of the extracellular domain of the GABAC
receptor were then built using MODELLER (19) by threading the aligned
sequence over the crystal structure of AChBP. The most energetically fa-
vorable models were selected from the MODELLER output ﬁle using the
ModelList program (http://www-cryst.bioc.cam.ac.uk/) and violations of the
Ramachandran plot were checked using RAMPAGE (21). The homology
model is similar to those previously reported for GABAC receptors (5–8),
and also similar to GABAA receptor models (11,12).
Docking was performed using FLExX (BioSolveIT, Sankt Augustin,
Germany). In particular, the docking model chosen is consistent with ‘‘ori-
entation 3’’ in Harrison and Lummis (5), where GABA has its amine close to
Tyr198, its carboxylate close to Arg104, and is within 5 A˚ from Arg158; this
was subtly different to the orientation of GABA obtained using a different
docking program, where the carboxylate group was within 3 A˚ of Arg158 (6).
Docking models are frequently inaccurate due to many simpliﬁcations used
in their implementation, whereas MD simulations can provide considerably
more accurate data as to the location of a ligand in a binding pocket by
reﬁning initial docking structures (22,23).
The use of classical molecular dynamics allowed us to simulate the whole
extracellular domain; mutations with natural amino acids are also adequately
described by the use of available classical force ﬁelds, while mutations with
unnatural amino acids or unusual residues may require a treatment with ab
initio techniques (24).
We used the program H11 (25) to evaluate the protonation state of the
protein ionizable groups by calculating their pKa shift with respect to the
standard pKa at neutral pH. After the protonation procedure, the total number
of atoms was 16,915 and the total charge of the system was neutral. The
GABA atomic partial charges were the ESP partial charges (26) calculated at
a density functional theory level with the CPMD code (27), using the PBE
gradient corrected functional for the exchange and correlation potential (28)
and norm conservingMartins-Troulliers pseudopotentials (29), with a kinetic
energy cutoff for the wavefunction expansion in plane waves of 70 Ry. The
GABAC receptor ECD was surrounded by 18,314 TIP3P water molecules in
a periodically repeated truncated octahedral box. To reproduce physiological
conditions, 0.15M dissociated KCl was added (equivalent to 49 K1 ions and
49 Cl ions in our system). The electrostatic contributions were evaluated
with the particle mesh Ewald method (30) using a cutoff for the direct space
sum of 10 A˚. We used an integration time step of 2 fs and constrained the
bonds’ length involving hydrogens with the SHAKE algorithm (31).
After a preliminary minimization, we equilibrated the system at constant
temperature and pressure. First, we thermalized the solution at 310 K for 60
ps with a Langevin thermostat (32) with a collision frequency g ¼ 1 ps1.
Then we performed a 5 ns molecular dynamics simulation with the system
coupled to a Berendsen thermostat at 310K and a Berendsen barostat at 1 atm
with coupling constants tT ¼ 2 ps and tP ¼ 2 ps, respectively (33). During
the ﬁrst nanosecond, we restrained the 20 (out of 209) amino acids closest to
the transmembrane domain of each subunit to mimic the presence of the
transmembrane domain. We then decreased the number of restrained resi-
dues from 20 to 10 for each subunit, to avoid restraints close to the GABA
binding site, and equilibrated the system for further 4 ns. Finally we started a
production run, which ran for 3.75 ns.
We analyzed the trajectory by evaluating the occurrence of the hydrogen
bonds and cation-p interactions involving GABA. To identify the hydrogen
bonds, we used as a criterion the distance between donor and acceptor (,3.5 A˚)
and the donor-hydrogen-acceptor angle (.120). To identify the cation-p
interactions, we used as a criterion the distance between the GABA amine
nitrogen and the center of mass of the phenyl ring (,5 A˚) and the angle
between the normal to the phenyl ring and the vector pointing from the ring
center of mass to the GABA amine nitrogen (,45).
RESULTS AND DISCUSSION
Stability of the homology model and binding of
GABA to the GABAC receptor
The root-mean-square displacement (RMSD) of the protein
backbone (calculated with respect to the initial minimized
FIGURE 1 Two adjacent GABAC receptor sub-
units showing the orientation of GABA in the
binding site after the initial minimization of the
docked structure in the homology model. The ligand
binding site consists of residues from loops A–C of
one subunit and loops D–F of the adjacent subunit
(left). A closeup of the binding pocket showing the
residues referred to in this study (right); the residue
labels are colored as the loops they belong to.
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structure) is shown in Fig. 3 (top) together with the RMSD of
the backbone of the residues in the binding pocket (bottom).
These were deﬁned as the residues within 10 A˚ fromGABA in
the minimized structure. The RMSD value stabilized at;3 A˚
for both the protein and the binding site with only 10 out of
209 residues per subunits restrained. The homology model is
therefore stable. Similar RMSDs were also calculated for the
mutated receptors (34).
GABA remained bound to the GABAC receptor for the
whole MD simulation. Its carboxylate group was always
hydrogen-bonded to Arg104, but the amine group was more
mobile. During the ﬁrst 2 ns of the production run, the amine
group formed a cation-p interaction with Tyr102, then GABA
rapidly rotated ;100 to form a cation-p interaction with
Tyr198, as in the initial conﬁguration. Two MD snapshots
representative of the two orientations are shown in Fig. 4.
Translations and rotations of GABA are shown in Fig. 5,
where we monitored the distance between the position of the
GABA center of mass at the beginning and at a generic time
of the production run and the modulus of the angle between
the lines passing through the center of mass and the amine
nitrogen at the beginning and at a generic time of the pro-
duction run. Very similar trends were found for the angle
involving the carboxylate carbon rather than the amine ni-
trogen (34). Besides interacting with GABA, Arg104 formed
on average 1.53 hydrogen bonds with Asp81 (equivalent to
the sum of the time occurrence percentages of the hydrogen
bonds between Arg104 and Asp81 divided by 100), of which
0.74 were as acceptor and 0.79 as donor.
Further binding partners of GABA were also identiﬁed in
the two stable orientations. These were: Ser168, which formed
hydrogen bonds with the carboxylate group; Gln83 and
Glu220, which formed hydrogen bonds with the amine group,
when GABA performed the cation-p interaction with Tyr102;
Ser243, which formed hydrogen bonds with the carboxylate
group; and Tyr198, which formed hydrogen bonds with the
amine group, when GABA performed the cation-p interac-
tion with Tyr198. Further details of the time occurrences of
FIGURE 2 Multiple sequence alignment
of representative GABAC, AChBP, GABAA,
glycine, and 5-HT3A receptor subunits
(GABAC r1 receptor subunit numbering).
The binding loops A–F are indicated by
lines above the alignment. The residues in
the binding pocket shown in Fig. 2 are
in solid boxes. Based on the secondary
structure of AChBP, residues belonging
to a-helices, b-sheets, and 310-helices are
labeled with a, b, and n, respectively.
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these interactions are shown in Fig. 6. On average, the car-
boxylate group formed 1.67 hydrogen bonds with Arg104,
0.53 with Ser243, and 0.50 with Ser168, while for the amine
group the data show 0.34 with Gln83, 0.33 with Tyr198, 0.29
with Glu220, 0.20 with Ser242, and 0.14 with Tyr241 giving a
total of 3.82 hydrogen bonds. GABA formed on average 0.31
cation-p interactions with Tyr102 and 0.41 with Tyr198, giv-
ing a total of 0.72 cation-p interactions. These results suggest
a possible conﬂict with the experimental data, which indicate
a cation-p interaction only with Tyr198. Tyr102 is clearly
important, but has been proposed to be involved predomi-
nantly in gating but not binding (7). However, it may be that
the interaction with Tyr102 is nonproductive, i.e., cannot re-
sult in gating, but is perhaps important for allowing GABA to
interact with other residues, e.g., Ser168, which has been
shown to be important for binding (6,10).
We did not observe any bond of GABA with the other
critical binding pocket arginine, Arg158, during the whole
simulation. In our initial conﬁguration from the docking, both
Arg104 and Arg158 were initially within 5 A˚ from GABA
(considering any atom of the residues), which remained in the
binding pocket for all the simulations, although the carbox-
ylate group was closer to Arg104 and remained too far from
the side groups of Arg158 to form hydrogen-bond interac-
tions.While we cannot completely exclude some inﬂuence of
the initial conditions, GABA was free to reorient itself and
the system was equilibrated for a sufﬁciently long time to
show whether Arg158 was a better binding partner than
Arg104 for GABA. Thus we can infer that Arg104 has a more
important role in binding GABA than Arg158, although the
latter does have a number of interactions as discussed below.
During the production run, Arg158 formed hydrogen bonds
with other residues: on average 0.96 with Gln160, 0.92 with
Leu166, and 0.18 with Ala199. To test the effects of Arg158
mutations, we performed molecular dynamics simulations of
the Arg158Ala, Arg158Glu, and Arg158Lys mutant receptors,
with the same simulation protocol used for the wild-type
receptor. The hydrogen bond between the NH group of
Leu166 and the oxygen of the carboxylic group of the residue
at position 158 was maintained in all cases, with fairly high
occurrences (92% for Arg158, 96% for Ala158, 80% for
Glu158, and 99% for Lys158, which also acted as a donor
through its NH group for another hydrogen bond with Leu166
with 61% occurrence). The side chain of the positively
charged Arg158 and Lys158 formed a rather infrequent (18%
in both cases) hydrogen bond with Ala199, but only Arg158
interacted with Glu160, with the three nitrogens of its side
group acting, in turn, as donors for an average of 0.96 hy-
drogen bonds. The two oxygens of the negatively charged
carboxylate group of Glu158 formed hydrogen bonds with
Ser243 with an occurrence of 62% each, while the neutral side
chain of Ala158 did not interact with any residue. The muta-
FIGURE 3 Root mean-square displacement of the protein backbone
atoms (top) and of the backbone of the residues of the binding pocket
(bottom) during the molecular dynamics. The residues of the binding pocket
were deﬁned as those with a distance of 10 A˚ from the initial position of
GABA. The dotted line at 1 ns indicates when the restrained residues were
reduced from 20 to 10 per subunit; the dashed line at 5 ns indicates the start
of the production run.
FIGURE 4 Two representative MD snapshots showing
the two orientations of GABA during the simulation: on the
left GABA forms hydrogen bonds with Arg104 and Ser168
and cation-p interactions with Tyr102, while on the right it
forms hydrogen bonds with Arg104 and Ser243 and cation-p
interactions with Tyr198.
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tions also indirectly affected the binding of GABA, in dif-
ferent ways for the different mutations. Speciﬁcally in the
Arg158Lys receptor, the GABA carboxylate group did not
bind to Arg104. It formed, on average, 0.21 hydrogen bonds
with Lys158, 0.34 with Ser242, 0.15 with Ser243, and 0.09 with
Ser168; the GABA amine group maintained on average 0.32
cation-p interactions with Tyr198 and 0.49 hydrogen bonds
with Tyr198, 0.26 with Met156, and 0.48 with Ser168. In the
Arg158Glu receptor, the GABA carboxylate group did in-
teract with Arg104 (with an average of 1.37 hydrogen bonds,
plus 0.89 and 0.96 hydrogen bonds with Ser168 and Ser242,
respectively), but the amine group did not form any cation-p
interaction with Tyr198 or any other residues. It did, however,
form hydrogen bonds with Glu158 (with an occurrence of
52%) and very infrequently with Ser243 (6%) and Glu168
(6%). In the Arg158Ala receptor, the GABA carboxylate
group interacted with two of the nitrogen groups of the side
chain of Arg104 (forming on average 2.50 hydrogen bonds),
and with the two serines Ser168 and Ser243, forming on av-
erage 0.97 and 0.14 hydrogen bonds, respectively; the
GABA amine group also maintained a cation-p interaction
with Tyr198 for 60% of the production run, and was also in-
volved in, on average, 0.42 and 0.91 hydrogen bonds with
Tyr247 and Leu166, respectively. Thus our data suggest that
the lack of function in the Arg158 mutant receptors is due to
changes in the hydrogen-bond network, which could affect
the binding of GABA and/or the links between the binding
site and channel opening.
There has been a previous MD investigation of the extra-
cellular domain of the GABAC receptor (8), based on a ho-
mology model built on a different structure of AChBP (from
Aplysia californica at 2.02 A˚ resolution (35)). In this study,
the chosen orientation of GABA from a docking procedure
has similarities with ours: the GABA carboxylate group
FIGURE 5 The distance of the GABA center of mass from its position at
the beginning of the production run (top) in the GABAC receptor; the
modulus of the angle u between the lines passing through the GABA amine
nitrogen and the GABA center of mass at the beginning and at a generic time
of the production run (bottom).
FIGURE 6 Time occurrences with the corresponding percentages over the
production run of the bonds formed by GABA in the GABAC receptor: (a)
Hydrogen bonds involving the GABA carboxylate group; the solid and
shaded colors indicate the two oxygen atoms in the carboxylate group. (b)
Hydrogen bonds involving the GABA amine group. (c) Cation-p interac-
tions involving the GABA amine group. The labels used to indicate the
atoms involved in the hydrogen bonds correspond to the atom types used in
the AMBER package.
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forms a salt-bridge with Arg104 and the amine group interacts
with Tyr198 and Tyr241. A molecular dynamics study was
performed for 7 ns on this structure, with partial solvation
limited to sphere of 20 A˚ radius around the neurotransmitter,
with the AMBER simulation package; it was found that
GABA was very unstable in the binding site and interactions
with important amino acids disappeared. In an additional
simulation, where the docking procedure was performed on a
structure obtained by a molecular dynamics equilibration,
GABA was more stable with recorded interactions between
the carboxylate group and Arg104, although no quantitative
information is available for comparison with our data.
Mutations of Arg104 with Ala, Glu, and Lys
To further test the role of Arg104 and to mimic previous ex-
perimental studies, we substituted Arg104 in each subunit in
turn with Ala, Glu, and Lys in the homology model, and
performed a new set of classical molecular dynamics simu-
lations of the whole GABAC receptor extracellular domain in
aqueous solution. The computational details, including the
minimization and equilibration procedures and initial posi-
tion of the ligand, were the same as for the wild-type receptor.
The substitution of the positively charged Arg with the
neutral Ala produced a receptor with a total charge of 5e;
hence, we added ﬁve positively charged (Na1) counterions to
neutralize the system. However, GABA was not stable in the
binding pocket, and indeed, it completely exited the protein
4.6 ns into the equilibration. During the ﬁrst ;3 ns of the
equilibration, the GABA carboxylate group bound to Arg158,
conﬁrming that this group preferred to bind to a positively
charged residue. However, these hydrogen bonds were not as
stable or as frequent as those previously formed by GABA
and Arg104, and indicate that Arg158 is a less favorable
binding partner than Arg104. The carboxylate group also
formed infrequent bonds with Thr201 and Ser242. The GABA
amine group formed a cation-p interaction with Tyr198 and
also a hydrogen bond with the carboxylic oxygen of Tyr198.
There were also infrequent hydrogen bonds with Met156,
Tyr200, and Ser197. After 3 ns of equilibration GABA oscil-
lated inside the binding site for ;1 ns with very infrequent
interactions and then left the binding site and the whole ECD.
In the 4.6-ns equilibration MD simulation before GABA
exited, the GABA carboxylate group formed, on average,
0.61 hydrogen bonds with Arg158, 0.12 with Thr201, and
0.06 with Ser242; the GABA amine formed 0.33 hydrogen
bonds with Tyr198, 0.09 with Met156, 0.12 with Tyr200, and
0.11 with Ser197. Ala104 formed, on average, 1.36 hydrogen
bonds with Asp81, of which 0.37 were as acceptor and 0.99
as donor.
The experimental data revealed a very large increase
(;10,000-fold) in EC50 when Arg
104 was substituted with
Ala (6). These data are consistent with our simulation, which
indicates that the stability of GABA inside the ECD dra-
matically decreased when Arg104 is replaced with Ala; indeed
the decrease was so dramatic that GABA rapidly exited the
binding site.
We then substituted the ﬁve subunits of the homology
model with Glu at position 104. Glu has a negative charge of
–e, hence the total charge of the system was 10e, and we
added 10 counterions (Na1) to neutralize the total charge.
During the production run, GABA underwent large dis-
placements and rotations, as seen in Fig. 7, which shows the
distance between the positions of the GABA center of mass
at the beginning and at a generic time of the production
run (top), and the modulus of the angle between the lines
passing through the center of mass and the amine nitrogen at
the beginning and at a generic time of the production run
(bottom).
In this simulation, the GABA carboxylate group found a
new binding partner: Arg249. Hydrogen bonds between the
GABA carboxylate group and Arg249 (0.91 in the production
run) were present intermittently for much of the simulation;
however, these bonds were considerably less frequent than
those with Arg104 in the wild-type receptor. The carboxylate
group also formed, on average, 0.31 hydrogen bonds with
Tyr241, and the amine group formed infrequent hydrogen
bonds with Tyr102 (0.15 on average) and Asp219 (0.16). In
FIGURE 7 The distance of the GABA center of mass in the Arg104Glu
GABAC receptor from its position at the beginning of the production run
(top); the modulus of the angle u between the lines passing through the
GABA amine nitrogen and the GABA center of mass at the beginning and at
a generic time of the production run (bottom).
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summary, an average of 1.47 hydrogen bonds were formed.
There were no cation-p interactions. Details of the time oc-
currences of these bonds can be seen in Fig. 8. Glu104 also
formed, on average, 3.17 hydrogen bonds with Asp81 (0.96 as
acceptor and 1.00 as donor), with Lys211 (1.13 as acceptor)
and with Ser168 (0.08 as acceptor).
The experimental data revealed another large increase
(;40,000-fold) in EC50 when Arg
104 was substituted with
Glu (6). Again the simulation indicates that the stability of
GABA inside the ECD dramatically decreased when Arg104
was replaced with Glu; GABA formed, on average, signif-
icantly fewer bonds with the surrounding residues (1.47
hydrogen bonds and no cation-p interactions) than in the
wild-type receptor. Interestingly, as in the previous simula-
tion, GABA appeared to prefer to interact with another Arg,
but in this case it was Arg249, perhaps because this was more
distant from the unfavorable negatively charged Glu.
Finally, we substituted Arg104 with Lys, which has the
same positive charge; hence the total charge of the proteinwas
neutral and we did not add any counterions. The distance
between the position of the GABA center of mass at the be-
ginning and at a generic time of the production run, and the
modulus of the angle between the lines passing through the
center ofmass and the amine nitrogen at the beginning and at a
generic time of the production run are shown in Fig. 9. GABA
underwent relatively small rotations and overall remained
reasonably close to its initial position. Unexpectedly, it only
formed very infrequent (0.07) hydrogen bonds with Lys104. It
also formed 1.17 hydrogen bonds with Ser243, 0.52 with
Ser168, 0.07 with Thr244, and 0.07 with Ser242. The amine
group formed, on average, 0.30 and 0.22 hydrogen bondswith
Tyr198 and Thr244, and 0.32, 0.52, and 0.20 cation-p inter-
actions with Tyr198, Tyr241, and Tyr247, respectively. Details
of the time occurrences of these bonds can be seen in Fig. 10.
The average number of hydrogen bonds (2.42) is signiﬁcantly
smaller than for the wild-type receptor, while the number of
cation-p interactions (1.14) is larger. Lys104 formed, on
average, 2.13 hydrogen bonds with other residues of the
GABAC receptor, of which 1.34 are with Asp
81 (0.94 as accep-
tor and 0.40 as donor) and 0.79 are with Gln83 (as donor).
The experimental data showed that the receptor was in-
sensitive to GABA up to a concentration of 30,000 mMwhen
Arg104 was substituted with Lys. Our simulations suggest
that the decrease in the number of hydrogen bonds and/or the
FIGURE 9 The distance of the GABA center of mass in the Arg104Lys
GABAC receptor from its position at the beginning of the production run
(top); the modulus of the angle u between the lines passing through the
GABA amine nitrogen and the GABA center of mass at the beginning and at
a generic time of the production run (bottom).
FIGURE 8 Time occurrences with the corresponding percentages over the
production run of the bonds formed by GABA in the Arg104Glu GABAC
receptor: (a) Hydrogen bonds involving the GABA carboxylate group; the
solid and shaded colors indicate the two oxygen atoms in the carboxylate
group. (b) Hydrogen bonds involving the GABA amine group. No cation-p
interactions were formed. The labels used to indicate the atoms involved in
the hydrogen bonds correspond to the atom types used in the AMBER
package.
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lack of interaction with Lys104 renders GABA incapable of
interacting sufﬁciently in the binding pocket to open the
channel.
In conclusion, the data from the simulations strongly
support the experimental data in suggesting a critical role for
Arg104. The simulation with the wild-type receptor revealed
hydrogen bonds between this residue and GABA for much of
the simulation, but GABA formed extremely infrequent
(,1%) bonds when this residue was mutated to Lys and no
bonds at all when it was mutated to Ala or Glu.
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